Literature DB >> 9139670

Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation.

P T Todorov1, M Deacon, M J Tisdale.   

Abstract

A material of Mr 24,000 has been isolated from a cachexia-inducing mouse tumor (MAC16) and shown to initiate protein degradation in isolated gastrocnemius muscle. Biological activity was destroyed by preincubation with peptide N-glycosidase F (PNGase F) and endo-alpha-N-acetylgalactosaminidase (O-glycosidase) but not by neuraminidase or trypsin. Antibody reactivity was destroyed by treatment with periodate, indicating carbohydrate moieties to be the antigenic determinants. Antigenic activity was also reduced by treatment with PNGase F and O-glycosidase and was completely destroyed by treatment with chondroitinase ABC but was unaffected by treatment with either trypsin or chymotrypsin, confirming that the N- and O-linked sulfated oligosaccharide chains were both the antigenic and biological determinants. Biosynthetic labeling of MAC16 cells using a combination of [35S]sulfate and [6-3H]GlcN gave a single component of Mr 24,000 containing both radiolabels. Similar material could not be isolated from a cell line (MAC13) originating from a tumor that does not cause cachexia in vivo. Digestion of 3H/35S material with PNGase F produced two fragments of Mr 14,000 and 10,000 containing both radiolabels, and digestion with O-glycosidase produced three fragments of Mr 14,000, 6,000, and 4, 000, the first two contained both radiolabels and the third contained only 3H. Digestion of the fragment of Mr 14,000 released by PNGase F with O-glycosidase also gave fragments of Mr 6,000 and 4, 000. The products from both digestions were acidic as determined by anion exchange chromatography on DEAE-cellulose. The negative charge on the fragment of Mr 4,000 was removed by treatment with alkaline phosphatase. This suggests that the charge originated from phosphate residues, and this has been confirmed by biosynthetic labeling of MAC16 cells with [32P]orthophosphate, where radiolabel was incorporated into material of Mr 24,000 and into the fragment of Mr 4,000 after treatment with O-glycosidase. To determine the size of the polypeptide core MAC16 cells were biosynthetically labeled with L-[2,5-3H]His which after chemical deglycosylation produced a major component of Mr 4,000. These results suggest a model for the Mr 24, 000 material consisting of a central polypeptide chain of Mr 4,000 and with phosphate residues that may be attached to the polypeptide or a short oligosaccharide chain containing GlcN, one O-linked sulfated oligosaccharide chain containing GlcN, and of Mr 6,000 and one N-linked sulfated oligosaccharide chain of Mr 10,000 also containing GlcN. Neither chain was cleaved into disaccharides with chondroitinase ABC, suggesting that the material is a sulfated glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9139670     DOI: 10.1074/jbc.272.19.12279

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  HSP70 natively and specifically associates with an N-terminal dermcidin-derived peptide that contains an HLA-A*03 antigenic epitope.

Authors:  Pawel Stocki; Xiao N Wang; Nicholas J Morris; Anne M Dickinson
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

2.  Anti-inflammatory peptide regulates the supply of heat shock protein 70 monomers: implications for aging and age-related disease.

Authors:  Timothy J Cunningham; Jeffrey I Greenstein; Joshua Loewenstern; Elias Degermentzidis; Lihua Yao
Journal:  Rejuvenation Res       Date:  2015-04       Impact factor: 4.663

3.  Anaerobic exercise reduces tumor growth, cancer cachexia and increases macrophage and lymphocyte response in Walker 256 tumor-bearing rats.

Authors:  Carina de Lima; Luciana E Alves; Fabíola Iagher; Andressa Franzoi Machado; Sandro J Bonatto; Diogo Kuczera; Carine Ferreira de Souza; Daniele Cristina Pequito; Ana Lúcia Muritiba; Everson Araújo Nunes; Luiz Cláudio Fernandes
Journal:  Eur J Appl Physiol       Date:  2008-08-08       Impact factor: 3.078

4.  Identification and characterization of sulfated glycoproteins from small cell lung carcinoma cells assisted by management of molecular charges.

Authors:  Masaaki Toyoda; Hiroyuki Kaji; Hiromichi Sawaki; Akira Togayachi; Takashi Angata; Hisashi Narimatsu; Akihiko Kameyama
Journal:  Glycoconj J       Date:  2016-06-18       Impact factor: 2.916

5.  Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF).

Authors:  K A Mirza; S M Wyke; M J Tisdale
Journal:  Br J Cancer       Date:  2011-06-14       Impact factor: 7.640

6.  Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia.

Authors:  Thomas L Schmitt; Marcus E Martignoni; Jeannine Bachmann; Kerstin Fechtner; Helmut Friess; Ralf Kinscherf; Wulf Hildebrandt
Journal:  J Mol Med (Berl)       Date:  2007-03-02       Impact factor: 5.606

7.  Cancer cachexia: impact, mechanisms and emerging treatments.

Authors:  Vanessa C Vaughan; Peter Martin; Paul A Lewandowski
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-10-25       Impact factor: 12.910

8.  Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes.

Authors:  Claudia L Yano; Gislaine Ventrucci; William N Field; Michael J Tisdale; Maria Cristina C Gomes-Marcondes
Journal:  BMC Cancer       Date:  2008-01-28       Impact factor: 4.430

9.  Mechanism of muscle protein degradation induced by a cancer cachectic factor.

Authors:  M J Lorite; M G Thompson; J L Drake; G Carling; M J Tisdale
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

10.  Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes.

Authors:  D Basso; C Millino; E Greco; C Romualdi; P Fogar; A Valerio; M Bellin; C-F Zambon; F Navaglia; N Dussini; A Avogaro; S Pedrazzoli; G Lanfranchi; M Plebani
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.